Premature Ovarian Insufficiency Linked to Autoimmune Diseases
By Elana Gotkine HealthDay Reporter
TUESDAY, Oct. 1, 2024 -- Women diagnosed with premature ovarian insufficiency (POI) have an increased prevalence of severe autoimmune diseases, according to a study published online Sept. 25 in Human Reproduction.
Susanna M. Savukoski, M.D., from Oulu University Hospital in Finland, and colleagues conducted a population-based registry study of 3,972 women diagnosed with spontaneous POI between 1988 and 2017 and 15,708 female population controls to examine the association with severe autoimmune diseases before and after POI diagnosis.
The researchers found that the prevalence of having at least one severe autoimmune disease was 5.6 percent in women with POI. Compared with controls, women with POI had an increased prevalence of several specific autoimmune diseases prior to the index date including polyglandular autoimmune diseases, Addison disease, vasculitis, systemic lupus erythematosus, rheumatoid arthritis, sarcoidosis, inflammatory bowel diseases, and hyperthyroidism. No difference was seen in the prevalence of type 1 diabetes or ankylosing spondylitis. During the first three years after POI diagnosis, the standardized incidence ratio for being diagnosed for the first time with a severe autoimmune disease was 2.8, which decreased to 1.3 after 12 years.
"The study results strengthen the hypothesis that autoimmune mechanisms play an important role in the pathogenesis of POI," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-10-02 06:00
Read more
- Stereotactic Radiosurgery Safe for Koos Grade I Vestibular Schwannomas
- Risk for Schizophrenia Increased With ED Visits Involving Hallucinogen Use
- Anxiety/Depression Linked to HRQoL Losses in Seropositive RA
- Get Off the Couch: Another Study Shows Sitting's Health Dangers
- CDC Says Some People May Need Extra Dose of COVID Vaccine
- FDA Approves Revuforj (revumenib) for the Treatment of Adult and Pediatric Patients with Relapsed or Refractory Acute Leukemia with a KMT2A Translocation
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions